Announcement on Obtaining the Drug Registration Certificate for the Adsorbed Inactivated (Three-component) Diphtheria-Tetanus-Pertussis Vaccine for Infants and Young Children

About this update from Cansino Biologics, Inc. Class A

Announcement on Obtaining the Drug Registration Certificate for the Adsorbed Inactivated (Three-component) Diphtheria-Tetanus-Pertussis Vaccine for Infants and Young Children The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Cansino Biologics, Inc. Class A